When it comes to medical treatment, healthcare professionals remain the most trusted source for information. According to a recent online survey of more than 600 AccentHealth viewers, 64% of viewers cite their healthcare professional as their source of information for prescription medicines, while 31% say they go to healthcare professionals for information on OTCs.
Missouri attorney general Chris Koster joined Jackson County prosecutor Jean Peters Baker and leaders from the Missouri Pharmacy Association and the Jackson County Sheriff’s Office to launch the state’s new voluntary retail Anti-Smurfing Campaign.
VoicePort announced a finalized agreement to deploy their services with WellSpan Health, a new client located in York, Pennsylvania, offering a vast array of inpatient, outpatient, home health and physician services.
A report on CBS' "60 Minutes" Sunday explored the aftermath of the nationwide outbreak of fungal meningitis linked to the New England Compounding Center that, according to the Centers for Disease Control and Prevention, has sickened 720 people in 20 states and led to 48 deaths.
While the Food and Drug Administration released draft guidance on regulations for biosimilars in February 2012, the final regulations have yet to appear. But already, everyone from analysts to trade groups to drug makers is preparing for a time when knock-off versions of biotech drugs will become available.
Republican and Democratic senators have re-introduced legislation that would ban patent settlements between branded and generic drug companies that critics allege violate antitrust laws, according to published reports.
Much of the policy-making conversation about health care in recent years has sought to highlight anticipated cost savings from technology innovation. Critics say this is an outgrowth of the American "fix-it" mentality. Others say technical solutions have yet to take hold outside of medical accounting applications. But there is general agreement that in the area of technologies to nurture medication adherence, the ground remains fertile.
Just about every healthcare practitioner recommends over-the-counter medicines to their patients. And nearly 3-out-of-4 make that OTC recommendation as the first therapy option, according to a recent survey released by the Consumer Healthcare Products Association.
This is another proof point that OTC medicines play an important role in holding down cost.
Nearly 98% of primary care physicians, nurse practitioners and pharmacists trust and recommend over-the-counter medicines to their patients, according to a new survey released Wednesday by the Consumer Healthcare Products Association.
The stakes are high in a case involving generic drug maker Actavis and the Federal Trade Commission that will soon go before the Supreme Court, the head of a generic drug industry lobbying group said in a conference call with reporters Tuesday.